[Research Report] The point-of-care molecular diagnostics market is projected to reach US$ 5,381.18 million by 2028 from US$ 2,230.94 million in 2021; it is expected to grow at a CAGR of 13.4% from 2021 to 2028.
Market Insights and Analyst View:
Point-of-Care Molecular Diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. Molecular diagnostics are shifting from centralized laboratories to decentralized point-of-care molecular testing, due to its simplicity, convenience, rapid turnaround time, and potential to improve patient outcomes. Owing to these advantages, it can be applied for diagnosis in low-resource or remote areas. Growing incidence of infectious diseases has considerably driven the demand for effective diagnosis. Increasing demand for diagnostic tools to control and eliminate infectious diseases, timely detection of causative agent, allowing effective treatment and disease control will fuel the market during the forecast period. Additionally, modern techniques are enabling a remarkable makeover in the field of molecular diagnostics. The global point-of-care molecular diagnostics market size is expected to reach US$ 5,381.18 million in 2028 from US$ 2,230.94 million in 2021. The market is estimated to grow with a CAGR of 13.4% from 2021-2028.
Growth Drivers and Challenges:
Rising Incidences of Infectious Diseases
The rising spread of infectious diseases increases the level and rate of testing. Moving molecular diagnostic testing for infectious diseases from laboratories to the point-of-care settings has the potential to revolutionize the rate and amount of testing to be performed. Molecular diagnostics is a more sensitive product and services that allows the detection of smaller concentrations of infectious pathogens, allowing diseases detection earlier than previously allowed. Point-of-care molecular diagnostics offers the potential to minimize the time required to get an actionable result and promote early infection detection, appropriate infection control measures, and enrollment into therapy clinical trials. The rising prevalence of influenza A/B, respiratory syncytial virus (RSV), and hospital-acquired infections (HAIs) boosts the demand for point-of-care molecular testing. Influenza and respiratory syncytial virus (RSV) point-of-care testing can improve patient treatment and infection control. Recently, point-of-care molecular diagnostics played a crucial role in detecting the COVID-19 infection. For COVID-19 infection detection, RT-PCR-based diagnostic tests are time-consuming, expensive, and require advanced equipment and specialized personnel. The high cost of diagnosis and the scarcity of test kits made it difficult to monitor the community transmission. As a result, rapid, affordable, and effective approaches for detecting COVID-19 viral infection in people were needed urgently. The easy and effective point-of-care molecular diagnostic devices allow on-site testing, which aids in the prevention of infection and control of its spread. Therefore, the rising demand for rapid and effective point-of-care molecular kits to detect infectious diseases drives the market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Point-of-Care Molecular Diagnostics Market: Strategic Insights
Market Size Value in US$ 2,230.94 million in 2021 Market Size Value by US$ 5,381.18 million by 2028 Growth rate CAGR of 13.4% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Point-of-Care Molecular Diagnostics Market: Strategic Insights
| Market Size Value in | US$ 2,230.94 million in 2021 |
| Market Size Value by | US$ 5,381.18 million by 2028 |
| Growth rate | CAGR of 13.4% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Restraints
Pricing Pressures owing to Reimbursement Cuts
The healthcare diagnostic market is currently suffering from a lack of reimbursements for different methods, which are crucial to patient diagnosis. The absence of reimbursements negatively impacts the market, with large marketplaces in major economies experiencing flat growth. Point-of-care molecular diagnostic tests face similar under-reimbursements issues across various countries worldwide. The reimbursement system is usually hostile to diagnostic tests. As the diagnostic tests are under-reimbursed, the prices of the tests are set too low, which eventually decreases the industry’s profitability and market size. Moreover, inefficient reimbursement structures constitute a barrier to the development of better diagnostic tests. Furthermore, reimbursement cuts may have a negative impact on clinical practice, as it is confronted with both a reluctance to employ diagnostics and a lack of improved tests in the future. Additionally, countries have their own reimbursement structures and policies when it comes to specific treatments. For instance, authorities in the US and Germany compensate hospitals for the total cost of treating a disease. Therefore, the hospitals bear the expense if the patient stays in the hospital longer than expected. This scenario can hinder the use of diagnostic tools if hospitals and healthcare centers believe that additional testing would result in a loss of profit or a financial loss per patient. Therefore, original equipment manufacturers (OEMs) of point-of-care molecular diagnostic devices face numerous bureaucratic and pricing challenges due to rigid reimbursement structures. Thus, reimbursement issues are creating pricing pressures on the manufacturers of point-of-care molecular diagnostic devices, which acts as a major restraint for the overall growth of the point-of-care molecular diagnostics market.
Report Segmentation and Scope:
The “Global Point-of-Care Molecular Diagnostics” is segmented based on product & services, technology, application, end user, and geography. Based on product and services, the global point of care molecular diagnostics market is segmented into assays and kits, instruments, and services and software. Point-of-care molecular diagnostics market based on the technology is segmented into PCR, isothermal nucleic acid amplification technology (INAAT), and other technologies. Point-of-care molecular diagnostics market based on the application is segmented into infectious diseases, oncology, haematology, prenatal testing, endocrinology, and other applications. Point-of-care molecular diagnostics market based on the end user is segmented into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others.
The point of care molecular diagnostics in health markets commercial based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)
Segmental Analysis:
Based on technology, the molecular diagnostics point of care market is segmented into PCR, isothermal nucleic acid amplification technology (INAAT), and other technologies. In 2021, the PCR segment is likely to hold the largest share of the market, however the INAAT segment is expected to grow at the fastest rate during the forecast period. Isothermal amplification of nucleic acid rapidly and efficiently accumulates nucleic acid sequences at a constant temperature. The amplification techniques are developed as an alternative to PCR and are used for biosensing targets, such as DNA, RNA, small molecules, proteins, cells, and ions. Amplicons, produced by the isothermal amplification methods, are utilized to construct versatile nucleic acid nanomaterials having various applications in biomedicine, bioimaging, and biosensing. The complex biochemical nature of clinical samples, low abundance of nucleic acid targets presents in clinical samples, and existing biosensor technology indicate that some form of nucleic acid amplification will be required to obtain clinically relevant sensitivities from the small samples used in point-of-care testing.
Based on product and services, the point of care molecular diagnostics market is segmented into assays and kits, instruments, and services and software. In 2021, the assays and kits segment is likely to hold the largest share of the market and is expected to grow at the fastest rate during the forecast period. Point-of-care molecular diagnostic assays and kits are specifically designed for physician offices, hospital critical care units, outpatient clinics, and community health posts. The assays and kits help in the early diagnosis of respiratory tract infections and women’s health and sexual health conditions. The assay kits are mostly used in life science research, environmental monitoring, and drug discovery and development. They are also used in various applications such as studying disease pathways, screening for potential drug candidates, and evaluating biopharmaceutical production processes. The POC ELISA (enzyme-linked immunosorbent assay) kits are widely used for detecting and quantifying proteins and antigens from samples. Target-specific ELISA kits are used to streamline immunodetection experiments.
Point-of-care molecular diagnostics market based on the application is segmented into infectious diseases, oncology, haematology, prenatal testing, endocrinology, and other applications. In 2021, the infectious diseases segment is likely to hold the largest share of the market however, oncology is expected to grow at the fastest rate during the coming years. Around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. The age-adjusted incidence of epilepsy in North America ranges between 16 out of 100,000 and 51 out of 100,000 person-years. The age-adjusted prevalence ranges from 2.2 of 1000 to 41 of 1000, depending on the reporting country. Partial epilepsy may constitute up to two-thirds of incident epilepsies. Incidence increases in lower socioeconomic populations. About 25% to 30% of new-onset seizures are thought to be provoked or secondary to another cause. Epilepsy incidence is highest in younger and older age groups and increases steadily after 50 years of age. The most common cause of seizures and epilepsy in older people is cerebrovascular disease.
Benzodiazepines such as diazepam, midazolam, or lorazepam are acceptable as the first-line medications for continuing seizure. The best second-line medication is unclear even after completing a highly anticipated randomized trial of benzodiazepine refractory status epilepticus- the established status epilepticus treatment trial (ESETT). Second-line medications include fosphenytoin, valproate, levetiracetam, and others.
Point of Care Molecular Diagnostics Market Analysis, Regional Analysis:
Based on geography, the global point-of-care molecular diagnostics market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In North America, the U.S. is the largest market for point-of-care molecular diagnostics market. The demand for point-of-care molecular diagnostic devices in the US market is being driven by the introduction of wearable medical devices, lab-on-a-chip technologies, and increased smartphone usage. Over the next few years, the industry will be transformed by the increasing availability of quick tests for identifying infectious diseases such as HIV, tuberculosis, and malaria, allowing clinicians and patients to visualize the results on a smartphone and make appropriate therapeutic decisions. The latest diagnostics industry advancements are driving the US point-of-care molecular diagnostics market, aiming to give an expedited diagnosis for quick clinical decision-making to assist treatment regimens.
Furthermore, the US was one of the worst-hit nations by the COVID-19 pandemic. Rapid testing and detection of the virus was needed for timely treatment. Point-of-care (POC) detection technologies that enable decentralized, quick, sensitive, and low-cost COVID-19 infection diagnostics are urgently required worldwide, including in the US. Thus, the COVID-19 pandemic opened lucrative growth opportunities for the US point-of-care molecular diagnostics market. Moreover, the rapidly increasing incidence of chronic diseases in the country is primarily driving the market. For instance, according to the American Cancer Society, an estimated 1.8 million new cancer cases were diagnosed in the US in 2020. Breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma, and liver cancer are frequent cancers.
Furthermore, according to research published by the Centers for Disease Control and Prevention in 2020, roughly 34.2 million Americans had diabetes. As per the same study, American youth has a greater incidence of diabetes. The prevalence of such diseases would drive demand for point-of-care molecular diagnostics in the country. Furthermore, there has been a notable increase in innovative and enhanced medical technologies in recent years. As a result of this expansion, sophisticated medical equipment was developed, and discoveries and breakthroughs in the healthcare business were stimulated. Furthermore, the US is home to several companies working on cutting-edge point-of-care molecular diagnostics. This factor is further expected to drive the US point-of-care molecular diagnostics market.
The introduction of real-time PCR (qPCR) extended the scope of molecular diagnostics in the medical field. In recent years, breakthrough tests in the US market have resulted from molecular diagnostic tests performed in a POC context or near patients. Molecular testing can improve the specificity and sensitivity of conventional near-patient and quick diagnostic tests, boosting the POC molecular diagnostic market in the US to new heights. The growing use of this diagnostic testing in laboratory settings is expected to increase its demand. The increased demand for early and precise diagnosis of a specific condition to provide appropriate treatment will lead to new technologies, thereby driving the US POC molecular diagnostics market.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global point-of-care molecular diagnostics market are listed below:
- In February 2021, Roche announces the filing for FDA Emergency Use Authorization for SARS-CoV-2 Rapid Antigen Test, allowing healthcare professionals to make fast decisions at the point-of-care.
- In March 2021, bioMérieux, announced BioFire Diagnostics, its subsidiary specialized in molecular syndromic infectious disease testing, has received U.S. Food and Drug Administration (FDA) De Novo authorization for the BIOFIRE® RP2.1 Panel.
- In November 2020, Enzo Biochem announced results of an analysis showing that tests processed on the Company’s proprietary GENFLEX™ molecular diagnostic platform are successfully able to detect the presence of currently known variants of COVID-19. While the Company’s PCR testing does not distinguish between different variants, positive samples can be further analyzed for variant identification. Rapid antigen tests currently available in the marketplace do not have this capability.
- In May 2021, Biocartis Group NV announced to have signed a new agreement with AstraZeneca, a global science-led biopharmaceutical company (LSE/STO/Nasdaq: AZN), aimed at providing access to rapid and easy-to-use Idylla™ EGFR testing products at selected hospital sites in Biocartis’ European and global distributor markets to support the identification of patients with EGFR mutations.
Point of Care Molecular Diagnostics Market Report Scope
Covid-19 Impact:
The US has the highest number of COVID-19 cases of all countries in North America. This has negatively impacted various industries, and supply and distribution chains in the region. During the pandemic, life science companies shifted their focus in the development of novel drugs for the treatment of life-threatening diseases. In addition, the demand for rapid testing equipment has also increased, which is playing a prominent role in the growth of the North America point-of-care molecular diagnostics market. Moreover, continuous spread of COVID-19 is bolstering the demand for point-of-care molecular diagnostic kits. The adoption of these kits is boosting new product developments and launches. In March 2021, Eurofins' Clinical Enterprise, Inc. obtained an Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a direct-to-consumer (DTC) version of its EmpowerDX COVID-19 Home Collection Kit. Similarly, in July 2020, Clinical Diagnostics of Eurofins USA announced the availability of its pooled PCR test to detect SARS-CoV-2, which would substantially lower the cost per PCR test for clients.
Competitive Landscape and Key Companies:
Some of the prominent players operating in the global point-of-care molecular diagnostics market include bioMérieux SA, F. Hoffmann-La Roche Ltd., Danaher Corporation, Enzo Biochem, Inc., Abbott, binx health, Inc., Meridian BioScience, Inc., Biocartis, Quidel Corporation, Bio-Rad Laboratories, Inc. among others. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their market share.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product & Services, Technology, Application, End User, Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
In 2021, the assays and kits segment is estimated to account for the largest market share in the global point-of-care molecular diagnostics market. POC molecular diagnostic assays and kits are specially designed for point of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts. POC molecular diagnostics assays and kits enable the early diagnosis of infectious diseases, cancer, and women’s health and sexual health conditions among others.
Asia Pacific is expected to be the fastest growing region in the point-of-care molecular diagnostics market. The growth of the point-of-care molecular diagnostics market in this region is primarily due to rising incidences of chronic diseases associated with geriatric population, expansion of key market players in this region, insufficient sophisticated central laboratory testing services, and potential cost effectiveness of POC molecular diagnosis.
Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. Molecular diagnostics are shifting from centralized laboratories to decentralized point-of-care molecular testing, due to its simplicity, convenience, rapid turnaround time, and potential to improve patient outcomes.
Increasing demand for diagnostic tools to control and eliminate infectious diseases, timely detection of causative agent, allowing effective treatment and disease control will fuel the market during the forecast period.
Various companies have made organic growth strategies in the point-of-care molecular diagnostics market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as F. Hoffmann-La Roche Ltd, Danaher amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.
North America dominates the global point-of-care molecular diagnostics market. Ongoing efforts by major market participants to strengthen their market position is an important factor contributing to the major share. Furthermore, several clinical studies investigating the efficiency and accuracy of novel molecular tests are also expected to contribute towards the market growth over the forecast period. Growing demand for rapid diagnosis and development of newer molecular diagnostic tests for DNA analysis have poised the region as a major market space.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Point-of-Care Molecular Diagnostics Market – By Product and Services
1.3.2 Global Point-of-Care Molecular Diagnostics Market – By Technology
1.3.3 Global Point-of-Care Molecular Diagnostics Market – By Application
1.3.4 Global Point-of-Care Molecular Diagnostics Market – By End User
1.3.5 Global Point-of-Care Molecular Diagnostics Market– By Geography
2. Global Point-of-Care Molecular Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Point-of-Care Molecular Diagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
5.1.2 Rising Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 Pricing Pressures owing to Reimbursement Cuts
5.3 Market Opportunities
5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics
5.4 Future Trends
5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting
5.5 Impact Analysis
6. Point-of-Care Molecular Diagnostics Market– Global Analysis
6.1 Global Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis
6.2 Global Point-of-Care Molecular Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product and Services
7.1 Overview
7.2 Point-of-Care Molecular Diagnostics Market, by Product and Services 2021 & 2028 (%)
7.3 Assays and Kits
7.3.1 Overview
7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services and Software
7.5.1 Overview
7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology
8.1 Overview
8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2021 & 2028 (%)
8.3 PCR
8.3.1 Overview
8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Point-of-Care Molecular Diagnostics Market Analysis – By Application
9.1 Overview
9.2 Point-of-Care Molecular Diagnostics Market, by Application 2021 & 2028 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Hematology
9.5.1 Overview
9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Prenatal Testing
9.6.1 Overview
9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Endocrinology
9.7.1 Overview
9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User
10.1 Overview
10.2 Point-of-Care Molecular Diagnostics Market, by End User 2021 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11. Global Point-of-Care Molecular Diagnostics Market – Geographic Analysis
11.1 North America: Point-of-Care Molecular Diagnostics Market
11.1.1 Overview
11.1.2 North America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 North America Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.4 North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.5 North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.6 North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7 North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.2 US Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.4 US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.2 Canada Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.4 Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.2 Mexico Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.4 Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.2 Europe: Point-of-Care Molecular Diagnostics Market
11.2.1 Overview
11.2.2 Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.2.4 Europe: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.2.5 Europe: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.2.6 Europe: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.2.7 Europe: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.2.7.1 UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.1 UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.2 UK: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.1.3 UK: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.1.4 UK: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.1.5 UK: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.2 Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.1 Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.2 Germany: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.2.3 Germany: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.2.4 Germany: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.2.5 Germany: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.3 France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.1 France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.2 France: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.3.3 France: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.3.4 France: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.3.5 France: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.4 Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.1 Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.2 Italy: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.4.3 Italy: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.4.4 Italy: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.4.5 Italy: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.5 Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.1 Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.2 Spain: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.5.3 Spain: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.5.4 Spain: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.5.5 Spain: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.6 Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.1 Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.2 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.6.3 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.6.4 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.6.5 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.3 Asia Pacific: Point-of-Care Molecular Diagnostics Market
11.3.1 Overview
11.3.2 Asia Pacific: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.4 Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.5 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.6 Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3.7 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
11.3.7.1 China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.1 China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.2 China: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.3 China Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.4 China: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.7.1.5 China Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3.7.2 Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.1 Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.2 Japan: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.3 Japan Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.4 Japan: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.7.2.5 Japan Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3.7.3 India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.1 India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.2 India: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.3 India Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.4 India: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.7.3.5 India Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3.7.4 Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.1 Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.2 Australia: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.3 Australia Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.4 Australia: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.7.4.5 Australia Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3.7.5 South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.1 South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.2 South Korea: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.3 South Korea Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.4 South Korea: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.7.5.5 South Korea Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3.7.6 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.1 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.2 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.3 Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.4 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.7.6.5 Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.4 Middle East & Africa: Point-of-Care Molecular Diagnostics Market
11.4.1 Overview
11.4.2 Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.3 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.4.4 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.4.5 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.4.6 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.4.7 Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.4.7.1 Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.1.1 Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.1.2 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.4.7.1.3 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.4.7.1.4 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.4.7.1.5 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.4.7.2 South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.2.1 South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.2.2 South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.4.7.2.3 South Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.4.7.2.4 South Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.4.7.2.5 South Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.4.7.3 UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.3.1 UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.3.2 UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.4.7.3.3 UAE: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.4.7.3.4 UAE: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.4.7.3.5 UAE: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.4.7.4 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.4.1 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.4.2 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.4.7.4.3 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.4.7.4.4 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.4.7.4.5 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.5 South and Central America: Point-of-Care Molecular Diagnostics Market
11.5.1 Overview
11.5.2 South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.3 South and Central America: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.5.4 South and Central America: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.5.5 South and Central America: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.5.6 South and Central America: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.5.7 South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.5.7.1 Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.1 Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.2 Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.5.7.1.3 Brazil: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.5.7.1.4 Brazil: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.5.7.1.5 Brazil: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.5.7.2 Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.1 Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.2 Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.5.7.2.3 Argentina: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.5.7.2.4 Argentina: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.5.7.2.5 Argentina: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.5.7.3 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.1 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.2 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.5.7.3.3 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.5.7.3.4 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.5.7.3.5 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market
12.1 Overview – Impact of COVID-19
12.2 Impact of COVID-19 on Point-of-Care Molecular Diagnostic Market
12.3 North America: Impact Assessment of COVID-19 Pandemic
12.4 Europe: Impact Assessment of COVID-19 Pandemic
12.5 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.6 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.7 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Point-of-Care Molecular Diagnostics Market– Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 bioMérieux SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Abbott
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERIDIAN BIOSCIENCE, INC.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Enzo Biochem Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biocartis
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Quidel Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Danaher
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BIO-RAD LABORATORIES INC.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 binx health, inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. US Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 6. US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 7. US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Point-of-Care Molecular Diagnostics Market, by Product and Services -Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Point-of-Care Molecular Diagnostics Market, by Product and Services -Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 22. UK: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 23. UK: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 24. UK: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 29. France: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 30. France: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 31. France: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 32. France: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 45. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 46. Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 47. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 48. Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 49. China: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 50. China Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 51. China: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 52. China Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 53. Japan: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 54. Japan Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 55. Japan: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 56. Japan Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 57. India: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 58. India Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 59. India: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 60. India Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 61. Australia: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 62. Australia Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 63. Australia: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 64. Australia Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 65. South Korea: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 66. South Korea Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 67. South Korea: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 68. South Korea Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 70. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 71. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 72. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 73. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 74. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 75. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 76. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 77. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 78. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 79. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 80. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 81. South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 82. South Africa: Point-of-Care Molecular Diagnostics Market, By Technology - Revenue and Forecast to 2028 (US$ Million)
Table 83. South Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 84. South Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 85. UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 86. UAE: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 87. UAE: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 88. UAE: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 91. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 92. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 93. South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 94. South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 95. South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 96. South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 97. Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 98. Brazil: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 99. Brazil: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 101. Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 102. Argentina: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 103. Argentina: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 104. Argentina: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 105. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 106. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 109. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market
Table 110. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market
Table 111. Glossary of Terms, Point-of-Care Molecular Diagnostics Market
LIST OF FIGURES
Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation
Figure 2. Point-of-Care Molecular Diagnostics Market Segmentation, By Region
Figure 3. Global Point-of-Care Molecular Diagnostics Market Overview
Figure 4. Assays and Kits Segment Held the Largest Share by Product and Services in Point-of-Care Molecular Diagnostics Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Point-of-Care Molecular Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Point-of-Care Molecular Diagnostics Market– Leading Country Markets (US$ Million)
Figure 8. Global Point-of-Care Molecular Diagnostics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Global Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 15. Global Point-of-Care Molecular Diagnostics Market – By Geography Forecast and Analysis – 2021- 2028
Figure 16. Market Positioning of Key Players in Global Point-of-Care Molecular Diagnostics Market
Figure 17. Point-of-Care Molecular Diagnostics Market, by Product and Services 2021 & 2028 (%)
Figure 18. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Point-of-Care Molecular Diagnostics Market, by Technology 2021 & 2028 (%)
Figure 22. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Point-of-Care Molecular Diagnostics Market, by Application 2021 & 2028 (%)
Figure 26. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Point-of-Care Molecular Diagnostics Market, by End User 2021 & 2028 (%)
Figure 33. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. North America: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 38. North America Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 39. North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 40. US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Europe: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 44. Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Europe: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 46. UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 53. Asia Pacific: Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 54. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 55. China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. Middle East & Africa: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 62. Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 63. Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 64. Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 65. South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 66. UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 67. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. South and Central America: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 69. South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 70. South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 71. Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 72. Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 73. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 74. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in North America
Figure 75. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Europe
Figure 76. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Asia-Pacific
Figure 77. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Middle East and Africa
Figure 78. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in South and Central America
Figure 79. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
The List of Companies - Point-of-Care Molecular Diagnostics Market
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
- binx health, Inc.
- Meridian BioScience, Inc.
- Biocartis
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Point-of-Care Molecular Diagnostics Market
Oct 2021
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Oct 2021
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Oct 2021
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Oct 2021
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Oct 2021
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Oct 2021
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
Oct 2021
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For